🇺🇸 FDA
Pipeline program

Antihemophilic factor, recombinant, manufactured protein-free

060201

Approved small_molecule completed

Quick answer

Antihemophilic factor, recombinant, manufactured protein-free for Hemophilia A is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 6 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hemophilia A
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials